25 January 2024 - KarXT has a novel mechanism of action, but there are significant uncertainties regarding long term efficacy ...
26 January 2024 - The EMA’s CHMP recommended three medicines for approval at its January 2024 meeting. ...
25 January 2024 - The outcomes from the December 2023 PBAC intracycle meeting are now available. ...
25 January 2024 - PHARMAC has joined the International Network of Agencies for Health Technology Assessment (INAHTA) - a network ...
18 January 2024 - NICE has published additional draft guidance on the use of remdesivir and the combination of tixagevimab ...
18 January 2024 - Surprise, surprise yet another underwhelming agenda. ...
18 January 2024 - Draft guidance for public consultation has been published by NICE. ...
22 January 2024 - The EMA has published a draft agenda for this week's CHMP meeting. ...
19 January 2024 - Around 300 people are set to benefit following NICE’s recommendation of talazoparib tosylate for treating a type ...
18 January 2024 - Since July 2023, there has been one in Germany for patients who suffer from acute myeloid leukaemia ...
18 January 2024 - Communiques for three HTA Review Reference Committee meetings held in December 2023 are now available. ...
17 January 2024 - NICE has published evidence-based recommendations on the use of olaparib (Lynparza) in combination with bevacizumab (Avastin) ...
15 January 2024 - The SMC, which advises on newly-licensed medicines for use by NHSScotland, has today published advice on ...
10 January 2023 - Sebelipase alfa is recommended as an option for the treatment of patients with Wolman disease only if ...
5 January 2024 - The Department of Health has published a revised agenda (version 3) for the March 2024 PBAC ...